DRUG STERILIZATION PROCESS REVIEW AT NDA/ANDA PREAPPROVAL INSPECTIONS
This article was originally published in The Tan Sheet
Executive Summary
DRUG STERILIZATION PROCESS REVIEW AT NDA/ANDA PREAPPROVAL INSPECTIONS rather than in the body of marketing applications is supported in recent industry comments to FDA. The Pharmaceutical Manufacturers Association and the Parenteral Drug Association submitted the comments in response to the agency's December 1993 final draft of its sterilization process validation guidelines ("The Tan Sheet" Dec. 20, 1993, in Brief).
You may also be interested in...
Supplement GMP Warning Letters Make Modest Debut In 2010
Finalization of a settlement between the Federal Trade Commission and Rexall Sundown regarding unsupported cellulite treatment claims for the firm's Cellasene dietary supplement hinges upon approval of two related class action settlements pending in California and Florida, according to FTC
In Brief
Combe sells most of its OTC brands
People In Brief
Perrigo promotes in pricing, planning